Logo image
Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection
Journal article   Open access   Peer reviewed

Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection

Rudragouda Channappanavar, Craig Fett, Jincun Zhao, David K Meyerholz and Stanley Perlman
Journal of virology, Vol.88(19), pp.11034-11044
10/2014
DOI: 10.1128/JVI.01505-14
PMCID: PMC4178831
PMID: 25056892
url
https://europepmc.org/articles/pmc4178831View
Published (Version of record) Open Access

Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV) caused an acute human respiratory illness with high morbidity and mortality in 2002-2003. Several studies have demonstrated the role of neutralizing antibodies induced by the spike (S) glycoprotein in protecting susceptible hosts from lethal infection. However, the anti-SARS-CoV antibody response is short-lived in patients who have recovered from SARS, making it critical to develop additional vaccine strategies. SARS-CoV-specific memory CD8 T cells persisted for up to 6 years after SARS-CoV infection, a time at which memory B cells and antivirus antibodies were undetectable in individuals who had recovered from SARS. In this study, we assessed the ability of virus-specific memory CD8 T cells to mediate protection against infection in the absence of SARS-CoV-specific memory CD4 T or B cells. We demonstrate that memory CD8 T cells specific for a single immunodominant epitope (S436 or S525) substantially protected 8- to 10-month-old mice from lethal SARS-CoV infection. Intravenous immunization with peptide-loaded dendritic cells (DCs) followed by intranasal boosting with recombinant vaccinia virus (rVV) encoding S436 or S525 resulted in accumulation of virus-specific memory CD8 T cells in bronchoalveolar lavage fluid (BAL), lungs, and spleen. Upon challenge with a lethal dose of SARS-CoV, virus-specific memory CD8 T cells efficiently produced multiple effector cytokines (gamma interferon [IFN-γ], tumor necrosis factor alpha [TNF-α], and interleukin 2 [IL-2]) and cytolytic molecules (granzyme B) and reduced lung viral loads. Overall, our results show that SARS-CoV-specific memory CD8 T cells protect susceptible hosts from lethal SARS-CoV infection, but they also suggest that SARS-CoV-specific CD4 T cell and antibody responses are necessary for complete protection. Virus-specific CD8 T cells are required for pathogen clearance following primary SARS-CoV infection. However, the role of SARS-CoV-specific memory CD8 T cells in mediating protection after SARS-CoV challenge has not been previously investigated. In this study, using a prime-boost immunization approach, we showed that virus-specific CD8 T cells protect susceptible 8- to 10-month-old mice from lethal SARS-CoV challenge. Thus, future vaccines against emerging coronaviruses should emphasize the generation of a memory CD8 T cell response for optimal protection.
SARS Virus - immunology Severe Acute Respiratory Syndrome - virology Dendritic Cells - immunology Humans Peptides - genetics Severe Acute Respiratory Syndrome - immunology Antigens, Viral - genetics Epitopes, T-Lymphocyte - genetics Peptides - administration & dosage CD4-Positive T-Lymphocytes - immunology Immunity, Cellular - drug effects Female Epitopes, T-Lymphocyte - immunology CD4-Positive T-Lymphocytes - virology Dendritic Cells - virology Antibodies, Viral - biosynthesis Immunity, Active Gene Expression Immunization Peptides - immunology Severe Acute Respiratory Syndrome - mortality Antigens, Viral - chemistry SARS Virus - pathogenicity Antigens, Viral - immunology Severe Acute Respiratory Syndrome - prevention & control Animals CD8-Positive T-Lymphocytes - virology Survival Analysis Immunity, Humoral - drug effects Immunologic Memory Mice CD8-Positive T-Lymphocytes - immunology Dendritic Cells - transplantation

Details

Metrics

Logo image